In a move to strengthen its worldwide footprint, Brinton Pharmaceuticals Ltd today inaugurated its Global Research and Development Centre in the United Kingdom at The Heath Business and Technical Park in Runcorn, Cheshire.
The new centre was officially opened during a visit by Nigel Huddleston MP, Minister of State at the Department for Business and Trade, in the presence of Brinton Pharma’s Chairman and Managing Director, Mr Rahul Kumar Darda.
Mr Huddleston said: “I am delighted to be inaugurating this new facility in Runcorn, which will help our domestic healthcare sector and create highly skilled jobs. This is an excellent example of the benefits UK-India trade can bring to both nations. By deepening our trading relationship, the UK-India trade deal can pave the way for even more investment opportunities and make it easier for UK and Indian companies, such as Brinton Healthcare UK Ltd, to do business in each other’s countries.”
Guests at the event included the Mayor of Halton, Cllr Mark Denett; Dr Shashank Vikram, IFS, Consul General of India, Birmingham; John Lewis MBE, Managing Director and owner of SOG Group; Dr Praveen Kumar Tavva, Director & Chief Scientific Officer, Brinton Healthcare UK Ltd and Dr Sonja Vujovic, Head of Consultancy and Innovation at University of Liverpool.
In a welcome address on behalf of SOG, Mr Lewis said: “Brinton announced last year its intention to expand its global operations by moving into to the UK, to create a dedicated research and development centre in the North of England. Naturally we are delighted they chose The Heath, above a number of other science parks, as the perfect location for their new R&D operation.
“The attendance today of the Minister of State for Business and Trade underpins the immense importance of Brinton’s arrival in the UK to our business and science sectors. I know Brinton have exciting plans to expand operations here over the next few years, creating hundreds of new skilled jobs. SOG are happy, willing and able to help them achieve their aspirations.”
Brinton with a global presence spanning across 32 countries sees the R&D Centre at The Heath as a strategic facility that will deepen its ongoing research in the areas of health and life sciences and support the company’s ambition to build next generation healthcare products. The company is planning to invest GBP 30 million over the next five years in the new facility.
“We have developed this facility to meet global standards. We appreciate the continuous support received from the UK Government at every stage. We are optimistic that this R&D Centre will come up with many new drugs that will change human health for the better,” said Mr Darda.
The R&D Centre’s primary focus is on innovations in topical skin delivery systems & focus on studying various skin disorders. “This is one growing segment where the world is looking towards path-breaking medical interventions and result-oriented solutions. We want to make use of this space and offer meaningful interventions,” added Mr Darda.
Welcoming the company to the Liverpool City Region, Mark Basnett, MD at LCR’s Growth Platform, said, “It is fantastic to welcome Brinton Pharmaceuticals, an innovation-led Indian multinational Pharmaceutical Company, to Halton and the wider Liverpool City Region. Their Global R&D Centre is exactly the type of inward investment that we, and our partners, work hard to bring to the region and is further evidence that we remain the natural choice for businesses in the Health & Life Science sector. We look forward to forging a long and successful partnership with them as they continue their global growth.”
Being committed to develop innovative formulations, Brinton has introduced 14 unique formulations, and the new R&D Centre at The Heath aims to develop affordable novel products using niche technologies. The company, interestingly, has world-class, multi-locational research and manufacturing partner facilities, and its products meet the most stringent standards of global regulatory authorities like WHO, GMP, PICS, PPB and NDA among others.
Brinton – the pharma biz conglomerate – has a solid presence in India, South-East Asia, Middle East, Latin America and the CIS countries and has ambitious growth plans for the UK which is why the global R&D Centre has been established in Runcorn. “We are banking on the UK to fulfil our international aspirations. The country has some of the finest pharma talent and offers plenty of growth opportunities. Brinton’s long-term business plan is anchored on research and innovation, and the R&D Centre at The Heath will play a key role in driving the company’s ambitions,” says Mr Darda
He adds: “Emerging technology is continuously redrawing the boundaries of pharma business. Our ambition is to seamlessly align technology and research to consolidate our global market standing as a company that offers high-quality portfolio of niche-differentiated products catering to the unmet needs of millions of people.”
About India-UK Fair Trade Agreement (FTA)
The investment relationship between UK and India already supports over half a million jobs across both economies and a forward-facing UK-India free trade agreement (FTA) creates new investment opportunities for British and Indian businesses.
A strong trade deal can boost the economic links between the UK and India and is expected to boost the UK economy by billions over the longer term. Total trade in goods and services between the UK and India in 2022 amounted to £34 billion, in current prices.
About The Heath
The Heath Business and Technical Park is a phenomenal regeneration success story. Formed in 2000, its owner and operator, SOG Ltd, has transformed a once single occupancy corporate facility into a thriving independent business park. The Heath now provides office and laboratory accommodation for around 120 individual organisations, ranging from business services and IT specialists to those at the cutting edge of science, research and advanced manufacturing. The Heath supports around 2,000 jobs.
For further information, telephone 01928 515988 or visit www.theheath.com
The Heath: Paul Smith Associates (PSA) 07771 623 007
Brinton Healthcare: Dr Praveen Kumar Tavva 07440 101 499